Researcher profile
Taylan Gurgenci
Affiliations
Organizations
Public evidence
4 connected articles
Medicinal cannabis for symptom control in advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of 1:1 tetrahydrocannabinol and cannabidiol.2025 · Europe PMCMedicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.2024 · Europe PMCExploring potential anti-inflammatory effects of medicinal cannabis.2023 · PubMed Central Open Access'What price do you put on your health?': Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer.2022 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.